Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Raizman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ophthalmic Plastic and Reconstructive Surgery|March 22, 2008
Exacerbation of undiagnosed ocular cicatricial pemphigoid after repair of involutional entropionMark P Hatton, Michael Raizman, C Stephen Foster
Journal of Cataract and Refractive Surgery|August 28, 2007
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenacTom Walters, Michael Raizman, Paul Ernest, et al.
Cornea|March 26, 2008
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablationRichard Lindstrom, Edward Holland, Stephen Lane, et al.
Journal of Cataract and Refractive Surgery|August 31, 2013
Reply: simulation of eye rubbingSamuel Masket, John Hovanesian, Michael Raizman, et al.
Journal of Cataract and Refractive Surgery|February 26, 2013
Use of a calibrated force gauge in clear corneal cataract surgery to quantify point-pressure manipulationSamuel Masket, John Hovanesian, Michael Raizman, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 23, 2019
Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical ApplicationsVictor L Perez, Barbara Wirostko, Michael Korenfeld, et al.
Cornea|March 26, 2008
Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplastyEdward J Holland, Stephen S Lane, Terry Kim, et al.
Journal of Cataract and Refractive Surgery|November 10, 2021
Persistent opioid use in cataract surgery pain management and the role of nonopioid alternativesRichard S Davidson, Kendall Donaldson, Maggie Jeffries, et al.
American Journal of Ophthalmology|November 15, 2019
Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment UveitisJohn Sheppard, Sunir Garg, Christopher Lievens, et al.
Current Eye Research|September 19, 2019
Optimization of Oxygen Dynamics, UV-A Delivery, and Drug Formulation for Accelerated Epi-On Corneal CrosslinkingJason Hill, Cailing Liu, Phillip Deardorff, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ophthalmic Plastic and Reconstructive Surgery|March 22, 2008
Exacerbation of undiagnosed ocular cicatricial pemphigoid after repair of involutional entropionMark P Hatton, Michael Raizman, C Stephen Foster
Journal of Cataract and Refractive Surgery|August 28, 2007
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenacTom Walters, Michael Raizman, Paul Ernest, et al.
Cornea|March 26, 2008
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablationRichard Lindstrom, Edward Holland, Stephen Lane, et al.
Journal of Cataract and Refractive Surgery|August 31, 2013
Reply: simulation of eye rubbingSamuel Masket, John Hovanesian, Michael Raizman, et al.
Journal of Cataract and Refractive Surgery|February 26, 2013
Use of a calibrated force gauge in clear corneal cataract surgery to quantify point-pressure manipulationSamuel Masket, John Hovanesian, Michael Raizman, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 23, 2019
Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical ApplicationsVictor L Perez, Barbara Wirostko, Michael Korenfeld, et al.
Cornea|March 26, 2008
Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplastyEdward J Holland, Stephen S Lane, Terry Kim, et al.
Journal of Cataract and Refractive Surgery|November 10, 2021
Persistent opioid use in cataract surgery pain management and the role of nonopioid alternativesRichard S Davidson, Kendall Donaldson, Maggie Jeffries, et al.
American Journal of Ophthalmology|November 15, 2019
Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment UveitisJohn Sheppard, Sunir Garg, Christopher Lievens, et al.
Current Eye Research|September 19, 2019
Optimization of Oxygen Dynamics, UV-A Delivery, and Drug Formulation for Accelerated Epi-On Corneal CrosslinkingJason Hill, Cailing Liu, Phillip Deardorff, et al.
Pageof 2